- Corporate Governance
- Board of Directors
- News Releases
- SEC Filings
- Financial Reporting
- Events and Webcasts
- Investor Alerts
Teligent is a specialty generic pharmaceutical company (NASDAQ: TLGT). Our mission is to be a leading player in the specialty generic prescription drug market.
We currently have 33 topical Abbreviated New Drug Applications (ANDAs) on file at the FDA, representing a total addressable market of approximately $2.0 billion (IMS, March 2017).
We sell a portfolio of prescription topical medicines and a growing number of hospital-based sterile injectable products, including cephalosporins.
‘’As we grow, we will keep our focus on execution, ownership and delivering on what we promise.’’